|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 767-772, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
RD Dowling, M Zenati, SA Yousem, AW Pasculle, RL Kormos, JA Armitage, BP Griffith and RL Hardesty
Bacterial pneumonia is the most common cause of early morbidity and
mortality (less than 2 weeks) after heart-lung transplantation. The
majority (76%) of cultures taken from human donor tracheas at the time of
explant grew bacteria. The abnormal immune response of the lung allograft
and the common finding of bacterial contamination of lung donors led us to
hypothesize that clinically silent bacterial contamination of the donor
lung progresses to pneumonia in the recipient and that antibiotic treatment
of donors will prevent the development of pneumonia in the recipient.
Inocula of Streptococcus pneumoniae were instilled into the left middle
lobe of normal and donor dogs to identify the number of bacteria that would
result in pneumonia in a normal animal and the amount that, when given to a
donor, would result in pneumonia in the recipient. Initial studies
established that inocula of 10(4) colony-forming units of S. pneumoniae did
not result in pneumonia in normal or immunosuppressed animals. When 10(4)
colony- forming units or as few as 10(2) were instilled into the left
middle lobe of donors 24 hours before explantation and use of the lung for
transplantation, severe acute bronchopneumonia developed in all 18
recipients. Treatment of donors with aerosol and intravenous antibiotics,
but not with either alone, prevented pneumonia in the recipients. We
conclude that bacterial contamination of the donor lung leads to pneumonia
in recipients. Intravenous and aerosol antibiotic treatment of donors with
bacterial contamination prevents pneumonia in canine lung recipients.
Treatment of human donors with this antibiotic regimen may decrease the
prevalence of early bacterial pneumonia.
ARTICLES
Donor-transmitted pneumonia in experimental lung allografts. Successful prevention with donor antibiotic therapy
Department of Surgery, University of Pittsburgh, Pa.
This article has been cited by other articles:
![]() |
V. Waters, S. Sokol, B. Reddy, G. Soong, J. Chun, and A. Prince The Effect of Cyclosporin A on Airway Cell Proinflammatory Signaling and Pneumonia Am. J. Respir. Cell Mol. Biol., August 1, 2005; 33(2): 138 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, W. Weder, G.A. Patterson, and S. Keshavjee Strategies to increase limited donor resources Eur. Respir. J., March 1, 2004; 23(3): 477 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Avlonitis, A. Krause, L. Luzzi, H. Powell, J. A. Phillips, P. A. Corris, F. K. Gould, and J. H. Dark Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Dowling, P. Williams, M. Zenati, B. P. Griffith, and R. L. Hardesty Infections and pathologic factors in the donor lung J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1263 - 1264. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |